PortfoliosLab logoPortfoliosLab logo
VFC vs. MED
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

VFC vs. MED - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in V.F. Corporation (VFC) and Medifast, Inc. (MED). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, VFC achieves a -4.81% return, which is significantly lower than MED's 3.18% return. Over the past 10 years, VFC has underperformed MED with an annualized return of -8.86%, while MED has yielded a comparatively higher -7.79% annualized return.


VFC

1D
-1.73%
1M
2.52%
YTD
-4.81%
6M
-7.72%
1Y
48.58%
3Y*
0.24%
5Y*
-24.48%
10Y*
-8.86%

MED

1D
-0.18%
1M
-12.47%
YTD
3.18%
6M
-2.74%
1Y
-22.01%
3Y*
-49.36%
5Y*
-46.41%
10Y*
-7.79%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VFC vs. MED - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
VFC
V.F. Corporation
-4.81%-13.83%16.64%-28.51%-60.38%-12.05%-12.00%51.70%-1.33%42.78%
MED
Medifast, Inc.
3.18%-39.39%-73.79%-38.34%-42.31%9.36%86.18%-9.73%82.11%72.33%

Correlation

The correlation between VFC and MED is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.21

Correlation (3Y)
Calculated over the trailing 3-year period

0.30

Correlation (5Y)
Calculated over the trailing 5-year period

0.33

Correlation (10Y)
Calculated over the trailing 10-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Dec 31, 1993

0.20

The correlation between VFC and MED shifts across timeframes, from 0.20 (all time) to 0.33 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

VFC:

$0.57

MED:

-$1.82

PS Ratio

VFC:

0.70

MED:

0.35

Total Revenue (TTM)

VFC:

$9.58B

MED:

$346.10M

Gross Profit (TTM)

VFC:

$5.16B

MED:

$242.70M

EBITDA (TTM)

VFC:

$961.05M

MED:

-$3.86M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VFC vs. MED — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VFC
VFC Risk / Return Rank: 7171
Overall Rank
VFC Sharpe Ratio Rank: 7373
Sharpe Ratio Rank
VFC Sortino Ratio Rank: 6969
Sortino Ratio Rank
VFC Omega Ratio Rank: 6666
Omega Ratio Rank
VFC Calmar Ratio Rank: 7575
Calmar Ratio Rank
VFC Martin Ratio Rank: 7373
Martin Ratio Rank

MED
MED Risk / Return Rank: 1919
Overall Rank
MED Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
MED Sortino Ratio Rank: 1717
Sortino Ratio Rank
MED Omega Ratio Rank: 1919
Omega Ratio Rank
MED Calmar Ratio Rank: 2020
Calmar Ratio Rank
MED Martin Ratio Rank: 2121
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VFC vs. MED - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for V.F. Corporation (VFC) and Medifast, Inc. (MED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VFCMEDDifference
Sharpe ratioReturn per unit of total volatility

+1.54

Sortino ratioReturn per unit of downside risk

+2.25

Omega ratioGain probability vs. loss probability

1.20

0.93

+0.27

Calmar ratioReturn relative to maximum drawdown

1.91

-0.59

+2.50

Martin ratioReturn relative to average drawdown

4.25

-1.00

+5.25

VFC vs. MED - Sharpe Ratio Comparison

The current VFC Sharpe Ratio is 1.01, which is higher than the MED Sharpe Ratio of -0.53. The chart below compares the historical Sharpe Ratios of VFC and MED, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

VFC vs. MED - Drawdown Comparison

The maximum VFC drawdown since its inception was -88.41%, smaller than the maximum MED drawdown of -98.40%. Use the drawdown chart below to compare losses from any high point for VFC and MED.


Loading charts...

Drawdown Indicators


VFCMEDDifference

Max Drawdown

Largest peak-to-trough decline

-88.41%

-98.40%

+9.99%

Max Drawdown (1Y)

Largest decline over 1 year

-25.57%

-37.39%

+11.82%

Max Drawdown (3Y)

Largest decline over 3 years

-63.66%

-90.91%

+27.25%

Max Drawdown (5Y)

Largest decline over 5 years

-86.78%

-96.29%

+9.51%

Max Drawdown (10Y)

Largest decline over 10 years

-88.41%

-96.76%

+8.35%

Current Drawdown

Current decline from peak

-79.14%

-96.26%

+17.12%

Average Drawdown

Average peak-to-trough decline

-21.69%

-50.87%

+29.18%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.46%

22.13%

-10.67%

Volatility

VFC vs. MED - Volatility Comparison

V.F. Corporation (VFC) has a higher volatility of 13.62% compared to Medifast, Inc. (MED) at 10.40%. This indicates that VFC's price experiences larger fluctuations and is considered to be riskier than MED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


VFCMEDDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.62%

10.40%

+3.22%

Volatility (6M)

Calculated over the trailing 6-month period

31.11%

31.76%

-0.65%

Volatility (1Y)

Calculated over the trailing 1-year period

48.45%

41.83%

+6.62%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

53.67%

45.28%

+8.39%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.02%

47.73%

-2.71%

Dividends

VFC vs. MED - Dividend Comparison

VFC's dividend yield for the trailing twelve months is around 2.11%, while MED has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
MED
Medifast, Inc.
0.00%0.00%0.00%7.36%5.69%2.71%2.30%3.08%1.75%2.06%2.57%0.82%
VFC
V.F. Corporation
2.11%1.99%1.68%5.27%7.28%2.69%2.26%1.91%2.65%2.32%2.87%2.14%

Financials

VFC vs. MED - Financials Comparison

This section allows you to compare key financial metrics between V.F. Corporation and Medifast, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B20222023202420252026
2.88B
76.04M
(VFC) Total Revenue
(MED) Total Revenue
Values in USD except per share items

VFC vs. MED - Profitability Comparison

The chart below illustrates the profitability comparison between V.F. Corporation and Medifast, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%55.0%60.0%65.0%70.0%75.0%20222023202420252026
55.6%
68.1%
Portfolio components
VFC - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, V.F. Corporation reported a gross profit of 1.60B and revenue of 2.88B. Therefore, the gross margin over that period was 55.6%.

MED - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a gross profit of 51.76M and revenue of 76.04M. Therefore, the gross margin over that period was 68.1%.

VFC - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, V.F. Corporation reported an operating income of 289.05M and revenue of 2.88B, resulting in an operating margin of 10.1%.

MED - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported an operating income of -3.30M and revenue of 76.04M, resulting in an operating margin of -4.3%.

VFC - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, V.F. Corporation reported a net income of 300.85M and revenue of 2.88B, resulting in a net margin of 10.5%.

MED - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Medifast, Inc. reported a net income of -2.12M and revenue of 76.04M, resulting in a net margin of -2.8%.


Frequently Asked Questions


VFC and MED have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VFC has higher volatility (13.62%) compared to MED (10.40%). In terms of maximum drawdown, VFC dropped -88.41% vs MED's -98.40%.

VFC currently has the higher Sharpe Ratio (1.01 vs -0.53), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for VFC and MED

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer